Topic

Sanofi

Sanofi raises sales outlook on Dupixent strength in boost for new CEO

Published 30 Jul, 2026 11:28am

Sanofi on Thursday raised its full-year sales forecast on the back of strong demand for blockbuster asthma drug Dupixent

Sanofi ends Phase 3 riliprubart trial after weak interim results

Published 10 Jun, 2026 12:09pm

An independent data monitoring committee found no ‌safety ⁠issues related to the drug during the interim analysi

Sanofi targets high single digit sales growth in 2026, plans share buyback

Published 29 Jan, 2026 12:50pm

In 2025, Sanofi completed a 5 billion euro share buyback program

Drugmakers brace for Europe pricing fight after Trump’s US price-cut deals

Updated 09 Jan, 2026 08:17am

Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after...

Drugmakers raise US prices on 350 medicines despite pressure from Trump

Published 01 Jan, 2026 07:36am

Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and...

Sanofi’s quarterly profit boosted by Dupixent and newer drugs, forecast unchanged

Published 24 Oct, 2025 11:24am

LONDON: France’s Sanofi reported a third-quarter profit that beat analysts’ expectations on Friday, boosted by...

EU stages antitrust raids in vaccines co

Published 01 Oct, 2025 07:27am

PARIS: French pharmaceutical group Sanofi announced on Tuesday that it is being investigated by the EU as part of a...

Sanofi revises annual sales growth expectations on strong Dupixent demand

Published 31 Jul, 2025 10:57am

France’s Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by...

Sanofi to buy US biopharma group Blueprint for over $9 billion

Published 02 Jun, 2025 12:43pm

PARIS: France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its...

Sanofi to invest at least $20 billion in the US through 2030

Published 14 May, 2025 09:39pm

French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through 2030,...

Sanofi meets estimates for fourth-quarter profit, plans 5 billion euros in buybacks

Published 30 Jan, 2025 11:43am

French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts’ estimates on Thursday, and...

Drugmakers to raise US prices on over 250 medicines starting Jan 1

Published 01 Jan, 2025 03:03am

NEW YORK: Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment...

Sanofi MS drug tolebrutinib misses goal in relapsing disease trials

Published 02 Sep, 2024 12:36pm

Sanofi’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...

France’s Sanofi in COVID-19 vaccine deal with Novavax

Published 10 May, 2024 01:28pm

PARIS: Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19...

Sanofi profit slips on generic competition and currency effects

Published 25 Apr, 2024 01:28pm

Sanofi’s first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple...

French shares lag European peers on Sanofi’s dour forecast

Published 28 Oct, 2023 05:58am

PARIS: European shares fell to near seven-month lows on Friday and clocked a second week of losses, with France’s...

Sanofi: considering consumer unit listing from late next year

Published 27 Oct, 2023 10:57am

French drugmaker Sanofi said on Friday it was looking into the separate listing of its Consumer Healthcare business...

Sanofi says arbitration court rejects Boehringer’s Zantac claims

Published 20 Jun, 2023 12:10pm

FRANKFURT: Sanofi said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration...

Sanofi Q1 profit buoyed by better-than-expected Dupixent sales

Published 27 Apr, 2023 11:26am

French drugmaker Sanofi on Thursday posted better-than-expected earnings for the first quarter as continued gains...

Sanofi hones in on type 1 diabetes in $2.9bn Provention Bio deal

Published 13 Mar, 2023 02:11pm

France’s Sanofi has agreed to acquire Provention Bio for $2.9 billion to bolster its work on type 1 diabetes therapy...

Judge to weigh key evidence ahead of first Zantac cancer trial

Published 17 Feb, 2023 11:26am

GSK Plc is expected to urge a California judge on Thursday to limit what expert testimony jurors can hear in the...

Makers to raise drug prices in US this month

Published 01 Jan, 2023 03:14am

Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to...

Sanofi trial failure halts work on breast cancer treatment amcenestrant

Published 17 Aug, 2022 10:41pm

Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast...

GSK, Sanofi and Haleon shares slump on Zantac litigation concerns

Published 12 Aug, 2022 12:35am

LONDON: Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines earlier this week, amid ...

Sanofi, GSK COVID vaccine found effective against Omicron

Published 24 Jun, 2022 01:38pm

PARIS: Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers...

Sanofi-GSK Covid booster jab shows positive results

Published 13 Jun, 2022 06:29pm

PARIS: French drug maker Sanofi said Monday a Covid booster shot it is developing with Britain’s GlaxoSmithKline has...

Healthcare companies Sanofi and GSK to seek COVID-19 vaccine regulatory approval

Published 23 Feb, 2022 03:39pm

PARIS: Healthcare companies Sanofi and GSK said they intend to submit data from both their booster and Phase III...

Sanofi sees strong earnings

Published 07 Feb, 2022 05:22am

PARIS: French pharmaceutical group Sanofi posted strong 2021 sales on Friday and expects another good performance in...

France's Sanofi eyes COVID-19 shot approval helping grow 2022 earnings

Published 04 Feb, 2022 02:48pm

PARIS: French drugmaker Sanofi said it still expected its COVID-19 vaccine to win approval in the first quarter and...

Healthcare group Sanofi forms research deal with the company Exscientia

Published 07 Jan, 2022 11:34am

PARIS: French healthcare company Sanofi , which has been under pressure to revive its drug pipeline after some...

BR100
BR30
KSE100
KSE30
KMI30

1D 5D 3M 6M 1Y

Forex
World
Commodity

Currency	Rate
USD PKR Interbank Selling / Sep 30	277.31
USD PKR Interbank Buying / Sep 30	277.11
USD to Japanese Yen / Sep 30	157.84
USD to Swiss Franc / Sep 30	0.83
Pound Sterling to USD / Sep 30	1.33
Euro to USD / Sep 30	1.13
SOFR % / Sep 29	3.88

Stock	Volume
S&P 500 / Sep 30	7,651.54
India Sensex / Sep 30	72,480.29
Tokyo Nikkei / Sep 30	66,753.72
Nasdaq / Sep 30	26,861.06
Hang Seng / Sep 30	24,613.27
FTSE 100 / Sep 30	10,606
Dow Jones / Sep 30	50,906.05
Germany DAX 30 / Sep 30	25,199.19
France CAC40 / Sep 30	7,964.51

Item	Value
Crude Oil USD/Barrel / Sep 30	90.56
Karachi Cotton PKR/37.32 KG / Sep 30	18,680
Gold 10 Grams PKR / Sep 30	378,631
Gold Spot USD/Ounce / Sep 30	4,154.77
Cotton US¢/pound / Sep 30	78.52
Petrol/Litre / Oct 1	387.54
Diesel/Litre / Oct 1	402.24

Gainers
Losers
Leaders

Stock	Price
Colony Tex.Mills Ltd / Sep 30 Colony Textile Mills Limited(CTM)	7.26 ▲ 1 (15.97%)
Kohinoor Spinning / Sep 30 Kohinoor Spinning Mills Limited(KOSM)	5.73 ▲ 0.77 (15.52%)
Lse Spac-I Ltd. / Sep 30 Lse Spac-I Limited(SPAC1)	20.41 ▲ 1.86 (10.03%)
Tri-Star Mutual / Sep 30 Tri-Star Mutual Fund Limited(TSMF)	16.57 ▲ 1.51 (10.03%)
Sindh Modaraba / Sep 30 Sindh Modaraba(SINDM)	33.28 ▲ 3.03 (10.02%)
Ghazi Fabrics / Sep 30 Ghazi Fabrics International Limited(GFIL)	26.38 ▲ 2.4 (10.01%)
Asim Textile / Sep 30 Asim Textile Mills Limited(ASTM)	113.96 ▲ 10.36 (10%)
Dadex Eternit / Sep 30 Dadex Eternit Limited(DADX)	150.32 ▲ 13.67 (10%)
First Punjab Modaraba / Sep 30 First Punjab Modaraba(FPJM)	29.04 ▲ 2.64 (10%)
Oilboy Energy / Sep 30 Oilboy Energy Limited(OBOY)	18.59 ▲ 1.69 (10%)

Stock	Price
Ashfaq Textile / Sep 30 Ashfaq Textile Mills Limited(ASHT)	50.57 ▼ -5.62 (-10%)
Ghani Chemworld Limited(PRS) / Sep 30 Ghani Chemworld Limited(PRS)(GCWLPRS)	118.83 ▼ -13.16 (-9.97%)
Burj Clean Energy Modaraba / Sep 30 Burj Clean Energy Modaraba(GEM)(GEMBCEM)	11.25 ▼ -1.15 (-9.27%)
The Thal Ind.Corp. / Sep 30 The Thal Industries Corporation Limited(TICL)	918.13 ▼ -92.07 (-9.11%)
Pakistan Services / Sep 30 Pakistan Services Limited(PSEL)	1,019.63 ▼ -99.15 (-8.86%)
Mandviwala / Sep 30 Mandviwala Mauser Plastic Industries(MWMP)	77.07 ▼ -7.14 (-8.48%)
S.G.Power / Sep 30 S.G. Power Limited(SGPL)	23.41 ▼ -1.84 (-7.29%)
D.M. Corporation / Sep 30 D.M. Corporation Limited(DMC)	165.33 ▼ -11.63 (-6.57%)
Cordoba Logistics / Sep 30 Cordoba Logistics & Ventures Limited(CLVL)	28.32 ▼ -1.94 (-6.41%)
EMCO Industries / Sep 30 Emco Industries Limited(EMCO)	32.10 ▼ -1.93 (-5.67%)

Stock	Volume
Pak Int.Bulk / Sep 30 Pakistan International Bulk Terminal(PIBTL)	73,446,994 ▲ 0.11
Kohinoor Spinning / Sep 30 Kohinoor Spinning Mills Limited(KOSM)	58,387,095 ▲ 0.77
Tasdeeq Info. Serv. / Sep 30 Tasdeeq Information Services Limited(TISL)	50,882,891 ▼ -0.09
Cnergyico PK / Sep 30 Cnergyico PK Limited(CNERGY)	28,308,841 ▲ 0.03
D.S. Ind. Ltd. / Sep 30 D.S. Industries Limited(DSIL)	21,823,804 ▲ 1.27
Arif Habib Corp / Sep 30 Arif Habib Corporation Limited(AHCL)	17,873,579 ▲ 0.1
Pak Refinery / Sep 30 Pakistan Refinery Limited(PRL)	17,817,038 ▲ 0.45
WorldCall Telecom / Sep 30 Worldcall Telecom Limited(WTL)	17,431,935 ▼ -0.01
S.G.Power / Sep 30 S.G. Power Limited(SGPL)	16,575,953 ▼ -1.84
F. Nat.Equities / Sep 30 First National Equities Limited(FNEL)	14,238,200 ▲ 0

Sanofi

Most Popular